Christoph Huber founded BioNTech SE and Ganymed Pharmaceuticals AG. Presently, he occupies the position of Chairman of Association For Cancer Immunotherapy.

He is also on the board of AFFiRiS AG, BioNTech SE and Ci3 Management UG.

In the past he was Chairman-Hematology & Oncology Department at The Johannes Gutenberg University of Mainz and Vice Chairman-Supervisory Board at Ganymed Pharmaceuticals AG.

He received a doctorate from the University of Innsbruck.